HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gilles Créhange Selected Research

Prostatic Neoplasms (Prostate Cancer)

5/2024Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.
11/2023Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU).
11/2023Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU).
8/2023Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review.
8/2023What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
1/2023Salvage Involved-Field and Extended-Field Radiation Therapy in Positron Emission Tomography-Positive Nodal Recurrent Prostate Cancer: Outcomes and Patterns of Failure.
12/2022Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
11/2022Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus.
11/2022Combining androgen deprivation and radiation therapy in the treatment of localised prostate cancer: Summary of level 1 evidence and current gaps in knowledge.
7/2022Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gilles Créhange Research Topics

Disease

40Prostatic Neoplasms (Prostate Cancer)
05/2024 - 11/2006
25Neoplasms (Cancer)
08/2023 - 11/2006
9Neoplasm Metastasis (Metastasis)
08/2023 - 12/2012
6Urinary Bladder Neoplasms (Bladder Cancer)
02/2023 - 10/2016
4Carcinoma (Carcinomatosis)
10/2023 - 11/2012
4Esophageal Neoplasms (Esophageal Cancer)
10/2019 - 06/2015
3Anus Neoplasms (Anal Cancer)
09/2018 - 11/2012
3Adenocarcinoma
06/2016 - 11/2006
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2023 - 12/2007
2Rectal Neoplasms (Rectal Cancer)
04/2007 - 11/2004
1Hypertension (High Blood Pressure)
05/2024
1Circulating Neoplastic Cells
05/2024
1Hot Flashes
05/2024
1Biliary Tract Neoplasms (Biliary Tract Cancer)
03/2024
1Adenoid Cystic Carcinoma (Cylindroma)
08/2023
1Lymphoma (Lymphomas)
06/2023
1Squamous Cell Carcinoma of Head and Neck
11/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022
1Brain Neoplasms (Brain Tumor)
09/2022
1Sarcoma (Soft Tissue Sarcoma)
12/2021
1Fibrosis (Cirrhosis)
12/2020
1COVID-19
01/2020
1Hemorrhage
01/2018
1Cognitive Dysfunction
01/2018
1Disease Progression
06/2016
1Chromosomal Instability (Chromosome Stability)
04/2015
1Alopecia (Baldness)
03/2014
1Mucositis
03/2014
1Stomach Neoplasms (Stomach Cancer)
01/2014
1Breast Neoplasms (Breast Cancer)
06/2013
1Unilateral Breast Neoplasms
06/2013
1Graft vs Host Disease (Graft-Versus-Host Disease)
12/2007
1Squamous Cell Neoplasms (Squamous Cell Cancer)
11/2006

Drug/Important Bio-Agent (IBA)

8AndrogensIBA
01/2023 - 10/2011
4Hormones (Hormone)IBA
05/2024 - 02/2013
3fluorocholineIBA
01/2023 - 01/2017
3AntigensIBA
01/2023 - 01/2020
3Biomarkers (Surrogate Marker)IBA
08/2021 - 02/2013
2LigandsIBA
01/2023 - 01/2020
2Fluorouracil (Carac)FDA LinkGeneric
09/2018 - 03/2014
2Docetaxel (Taxotere)FDA Link
08/2017 - 01/2017
2Protons (Proton)IBA
02/2013 - 07/2011
2Choline (Choline Chloride)IBA
12/2012 - 07/2011
1Androgen Receptors (Androgen Receptor)IBA
05/2024
1Abiraterone AcetateIBA
05/2024
1Prednisone (Sone)FDA LinkGeneric
05/2024
1Prostate-Specific Antigen (Semenogelase)IBA
05/2024
1spleen fibrinolytic proteinase (human) (SFP)IBA
03/2024
1Immune Checkpoint InhibitorsIBA
09/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2022
1capivasertibIBA
12/2021
1ipatasertibIBA
12/2021
1mesoglycanIBA
12/2020
1gallium 68 PSMA-11IBA
01/2020
1Gallium-68IBA
01/2020
1Iodine-125IBA
11/2018
1Mitomycin (Mitomycin-C)FDA LinkGeneric
09/2018
1Capecitabine (Xeloda)FDA Link
09/2018
1taxaneIBA
08/2017
1MetalsIBA
08/2017
1OxidesIBA
08/2017
1Paclitaxel (Taxol)FDA LinkGeneric
07/2017
1Carboplatin (JM8)FDA LinkGeneric
07/2017
1fluoromethylcholineIBA
01/2017
1Goserelin (Zoladex)FDA Link
06/2016
1PlatinumIBA
06/2015
1DNA (Deoxyribonucleic Acid)IBA
04/2015
1Leucovorin (Folinic Acid)FDA Link
03/2014
1Alanine Transaminase (SGPT)IBA
03/2014
1CreatinineIBA
03/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2014
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2014
1Cisplatin (Platino)FDA LinkGeneric
03/2014
1Trastuzumab (Herceptin)FDA Link
06/2013
1Citric Acid (Citrate)FDA LinkGeneric
07/2011
1CreatineIBA
07/2011
1PolyaminesIBA
07/2011
1Small Interfering RNA (siRNA)IBA
12/2007

Therapy/Procedure

47Radiotherapy
05/2024 - 11/2004
17Therapeutics
05/2024 - 11/2006
7Chemoradiotherapy
04/2018 - 11/2006
6Prostatectomy (Retropubic Prostatectomy)
05/2024 - 09/2012
6Drug Therapy (Chemotherapy)
02/2023 - 11/2006
5Re-Irradiation
10/2023 - 06/2022
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2023 - 12/2007
4Castration
08/2023 - 01/2020
3Proton Therapy
10/2023 - 11/2022
3Brachytherapy
04/2022 - 11/2015
3Cystectomy
12/2020 - 10/2016
2Precision Medicine
10/2021 - 08/2017
2Neoadjuvant Therapy
06/2013 - 11/2006
1Immunotherapy
09/2022
1Vasectomy (Vas Occlusion)
07/2022
1Salvage Therapy
01/2019
1Image-Guided Radiotherapy
12/2018
1Activities of Daily Living (ADL)
01/2018
1Injections
08/2017
1Adjuvant Chemoradiotherapy
01/2014
1Particle Accelerators
11/2013